Atossa Therapeutics
ATOS
$1.66
Share price
9.21%
Change (1 day)
151.52%
Change (1 year)
Categories
Earnings for Atossa Therapeutics (ATOS)
Earnings in 2023 (TTM): -$29.84 M
According to Atossa Therapeutics's latest financial reports the company's current earnings (TTM) are -$29.84 M. In 2022 the company made an earning of -$26.96 M a decrease over its 2021 earnings that were of -$20.61 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Atossa Therapeutics from 2011 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$29.84 M | 10.65% |
| 2022 | -$26.96 M | 30.84% |
| 2021 | -$20.61 M | 15.58% |
| 2020 | -$17.83 M | 3.41% |
| 2019 | -$17.24 M | 51.16% |
| 2018 | -$11.41 M | 40.41% |
| 2017 | -$8.13 M | 27.54% |
| 2016 | -$6.37 M | -47.49% |
| 2015 | -$12.13 M | -17.25% |
| 2014 | -$14.66 M | 35.91% |
| 2013 | -$10.79 M | 112.3% |
| 2012 | -$5.08 M | 46.53% |
| 2011 | -$3.47 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -56,993.84% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $1.11 B | -3,851.13% | 🇺🇸 USA |
 LabCorp LH | $0.77 B | -2,694.62% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $41.68 M | -239.72% | 🇺🇸 USA |
 NeoGenomics
NEO | -$90.19 M | 202.34% | 🇺🇸 USA |
 Enzo Biochem ENZ | -$9.61 M | -67.80% | 🇺🇸 USA |